154 related articles for article (PubMed ID: 28299651)
1. Runx1 Structure and Function in Blood Cell Development.
Bonifer C; Levantini E; Kouskoff V; Lacaud G
Adv Exp Med Biol; 2017; 962():65-81. PubMed ID: 28299651
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
3. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.
Ptasinska A; Assi SA; Mannari D; James SR; Williamson D; Dunne J; Hoogenkamp M; Wu M; Care M; McNeill H; Cauchy P; Cullen M; Tooze RM; Tenen DG; Young BD; Cockerill PN; Westhead DR; Heidenreich O; Bonifer C
Leukemia; 2012 Aug; 26(8):1829-41. PubMed ID: 22343733
[TBL] [Abstract][Full Text] [Related]
4. Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program.
Hoogenkamp M; Lichtinger M; Krysinska H; Lancrin C; Clarke D; Williamson A; Mazzarella L; Ingram R; Jorgensen H; Fisher A; Tenen DG; Kouskoff V; Lacaud G; Bonifer C
Blood; 2009 Jul; 114(2):299-309. PubMed ID: 19339695
[TBL] [Abstract][Full Text] [Related]
5. RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML.
Loke J; Assi SA; Imperato MR; Ptasinska A; Cauchy P; Grabovska Y; Soria NM; Raghavan M; Delwel HR; Cockerill PN; Heidenreich O; Bonifer C
Cell Rep; 2017 May; 19(8):1654-1668. PubMed ID: 28538183
[TBL] [Abstract][Full Text] [Related]
6. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.
Bras S; Martin-Lannerée S; Gobert V; Augé B; Breig O; Sanial M; Yamaguchi M; Haenlin M; Plessis A; Waltzer L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4986-91. PubMed ID: 22411814
[TBL] [Abstract][Full Text] [Related]
7. Human yolk sac-like haematopoiesis generates
Bruveris FF; Ng ES; Leitoguinho AR; Motazedian A; Vlahos K; Sourris K; Mayberry R; McDonald P; Azzola L; Davidson NM; Oshlack A; Stanley EG; Elefanty AG
Development; 2020 Oct; 147(20):. PubMed ID: 33028609
[TBL] [Abstract][Full Text] [Related]
8. Contributions of the histone arginine methyltransferase PRMT6 to the epigenetic function of RUNX1.
Lausen J
Crit Rev Eukaryot Gene Expr; 2013; 23(3):265-74. PubMed ID: 23879542
[TBL] [Abstract][Full Text] [Related]
9. Chromatin regulation by RUNX1.
Lichtinger M; Hoogenkamp M; Krysinska H; Ingram R; Bonifer C
Blood Cells Mol Dis; 2010 Apr; 44(4):287-90. PubMed ID: 20194037
[TBL] [Abstract][Full Text] [Related]
10. Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.
Willcockson MA; Taylor SJ; Ghosh S; Healton SE; Wheat JC; Wilson TJ; Steidl U; Skoultchi AI
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17841-17847. PubMed ID: 31431533
[TBL] [Abstract][Full Text] [Related]
11. Runx1 shapes the chromatin landscape via a cascade of direct and indirect targets.
Hass MR; Brissette D; Parameswaran S; Pujato M; Donmez O; Kottyan LC; Weirauch MT; Kopan R
PLoS Genet; 2021 Jun; 17(6):e1009574. PubMed ID: 34111109
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 C-terminal mutations impair blood cell differentiation by perturbing specific enhancer-promoter networks.
Jayne ND; Liang Z; Lim DH; Chen PB; Diaz C; Arimoto KI; Xia L; Liu M; Ren B; Fu XD; Zhang DE
Blood Adv; 2024 May; 8(10):2410-2423. PubMed ID: 38513139
[TBL] [Abstract][Full Text] [Related]
13. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
14. Runx transcription factors and the developmental balance between cell proliferation and differentiation.
Coffman JA
Cell Biol Int; 2003; 27(4):315-24. PubMed ID: 12788047
[TBL] [Abstract][Full Text] [Related]
15. An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies.
Wang H; Li W; Guo R; Sun J; Cui J; Wang G; Hoffman AR; Hu JF
Int J Cancer; 2014 Dec; 135(12):2783-94. PubMed ID: 24752773
[TBL] [Abstract][Full Text] [Related]
16. A Src family kinase-Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation.
Huang H; Woo AJ; Waldon Z; Schindler Y; Moran TB; Zhu HH; Feng GS; Steen H; Cantor AB
Genes Dev; 2012 Jul; 26(14):1587-601. PubMed ID: 22759635
[TBL] [Abstract][Full Text] [Related]
17. Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1-C/EBPalpha interaction.
Fujimoto T; Anderson K; Jacobsen SE; Nishikawa SI; Nerlov C
EMBO J; 2007 May; 26(9):2361-70. PubMed ID: 17431401
[TBL] [Abstract][Full Text] [Related]
18. RUNX transcription factors at the interface of stem cells and cancer.
Deltcheva E; Nimmo R
Biochem J; 2017 May; 474(11):1755-1768. PubMed ID: 28490659
[TBL] [Abstract][Full Text] [Related]
19. Runx1 is a co-activator with FOXO3 to mediate transforming growth factor beta (TGFbeta)-induced Bim transcription in hepatic cells.
Wildey GM; Howe PH
J Biol Chem; 2009 Jul; 284(30):20227-39. PubMed ID: 19494111
[TBL] [Abstract][Full Text] [Related]
20. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
